COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Single Application Brachytherapy in Cervical Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03110497
Recruitment Status : Unknown
Verified January 2018 by Dr Umesh Mahantshetty, Tata Memorial Hospital.
Recruitment status was:  Recruiting
First Posted : April 12, 2017
Last Update Posted : November 7, 2018
Information provided by (Responsible Party):
Dr Umesh Mahantshetty, Tata Memorial Hospital

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : April 17, 2019
Estimated Study Completion Date : April 17, 2020
Shrivastava S DK, Mahantshetty U, Engineer R, Patil N, Deshpande D, Tongaonkar H Comparing Low-Dose-Rate andHigh-Dose-Rate Intracavitary Brachytherapy in Carcinoma Cervix: Results From a Randomized Controlled Study. . Int J Radiat Oncol Biol Phys 2006, 1; 66.